FDA Panel Says Some Asthma Inhalers are Risky and are not Worth Taking.
A FDA Panel said Thursday that the risks of death and serious injury associated with certain of asthma inhalers are greater than the benefits of the drugs. The drugs discussed by panel were: Serevent, Advair, Foradil, and Symbicort.
Asthma is a chronic condition which affects about 22 million Americans, including 6.5 million children and is marked by narrowing of the airways, which causes sudden difficulty breathing. The inhalers are known as long-acting beta-agonists, or LABAs, and are designed to reduce tightening of the muscles around the airway caused by asthma.
It is estimated that six million asthma patients have been prescribed these types of medications. The FDA asked the panel expert panel for advice on whether to allow certain drugs to continue to be marketed for the treatment of asthma in children and adults. There have been concerns that the products increase the risk of asthma-related side effects.
Read more.............. http://askcrazy.com/
One dead, fire officer hospitalised after bee attack at Quarry Site in Sokode Gb...
Israel and Iran step back from further strikes after renewed clashes
Patients stranded as doctors, nurses refuse to see new patients over KATH CEO su...
Avenor Rural Bank CEO’s house destroyed by fire
Three arrested in Winneba for illegal mining near GWL water lines
Two pupils of Alice Elite Academy laid to rest after fatal school bus crash
Here are areas to be affected by ECG's planned maintenance on Tuesday
Family of civil engineer killed in alleged military shooting demands justice
SHS teacher allegedly beats female student over unpaid hostel fees
Blow to EU defence cooperation as France, Germany abandon joint fighter jet prog...
